Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-25-015320
Filing Date
2025-10-27
Accepted
2025-10-27 06:57:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10565
  Complete submission text file 0001214659-25-015320.txt   12570
Mailing Address 1-4-1, MARUNOUCHI CHIYODA-KU, TOKYO M0 100-8233
Business Address 1-1, SHIBAKOEN, 1-CHOME MINATO-KU, TOKYO M0 105-0011 81-3-6256-6000
Sumitomo Mitsui Trust Group, Inc. (Filed by) CIK: 0001475365 (see all company filings)

EIN.: 000000000 | State of Incorp.: M0
Type: SCHEDULE 13G/A
SIC: 6029 Commercial Banks, NEC
(CF Office: 02 Finance)

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Subject) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91046 | Film No.: 251417384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)